{ "labelLang" : "hun", "responseDate" : "2024-03-28 17:53", "content" : { "otype" : "BookChapter", "mtid" : 26107061, "status" : "APPROVED", "error" : "INCOMPLETE", "published" : true, "unhandledTickets" : 0, "oldTimestamp" : "2016-10-04T10:20:56.000+0000", "deleted" : false, "oldId" : 16107061, "lastRefresh" : "2023-05-05T11:56:57.469+0000", "lastModified" : "2016-10-04T10:20:56.000+0000", "created" : "2016-10-03T12:41:06.000+0000", "creator" : { "otype" : "Author", "mtid" : 10023881, "link" : "/api/author/10023881", "label" : "Börcsökné Endreffy Emőke (Klinikai molekuláris genetika)", "familyName" : "Börcsökné Endreffy", "givenName" : "Emőke", "published" : true, "oldId" : 10023881, "snippet" : true }, "lastDuplumOK" : "2018-10-22T13:55:08.584+0000", "lastDuplumSearch" : "2018-10-22T13:55:08.584+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000398, "link" : "/api/subtype/10000398", "label" : "Könyvfejezet (Könyvrészlet)", "name" : "Könyvfejezet", "nameEng" : "Chapter", "docType" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "listPosition" : 220, "published" : true, "oldId" : 10000398, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Markowitz, GS", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 59988215, "link" : "/api/authorship/59988215", "label" : "Markowitz, GS", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Markowitz", "givenName" : "GS", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 123317948, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 59988216, "link" : "/api/authorship/59988216", "label" : "D'Agati, VD", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "D'Agati", "givenName" : "VD", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 123317947, "snippet" : true } ], "title" : "Membranous glomerulonephritis", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 11580540, "link" : "/api/publicationidentifier/11580540", "label" : "Scopus: 84974815483", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "84974815483", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84974815483", "published" : false, "oldId" : 13421942, "snippet" : true } ], "firstPageOrInternalIdForSort" : "", "publishedYear" : 2014, "digital" : null, "printed" : null, "sourceYear" : 2016, "packet" : "(Börcsökné Endreffy Emőke (Klinikai molekuláris ge...); 2016.10.03. 14:40:34)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-05-05", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 1, "citedCount" : 1, "referenceList" : "Glassock, R.J., The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey (2010) Am J Kidney Dis, 56, pp. 157-167; \n\nJones, D.B., Nephrotic glomerulonephritis (1957) Am J Pathol, 33, pp. 313-329; \n\nMellors, R.C., Ortega, L.G., Holman, H.R., Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction (1957) J Exp Med, 106, pp. 191-202; \n\nMovat, H.Z., Mc, G.D., The fine structure of the glomerulus in membranous glomerulonephritis (lipoid nephrosis) in adults (1959) Am J Clin Pathol, 32, pp. 109-127; \n\nBeck, L.H., Jr., Bonegio, R.G., Lambeau, G., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy (2009) N Engl J Med, 361, pp. 11-21; \n\nGlassock, R.J., Secondary membranous glomerulonephritis (1992) Nephrol Dial Transplant, 7, pp. 64-71; \n\nSprangers, B., Bomback, A.S., Cohen, S.D., Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center (2012) Am J Nephrol, 36, pp. 78-89; \n\nTroyanov, S., Roasio, L., Pandes, M., Renal pathology in idiopathic membranous nephropathy: a new perspective (2006) Kidney Int, 69, pp. 1641-1648; \n\nCattran, D.C., Pei, Y., Greenwood, C.M., Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications (1997) Kidney Int, 51, pp. 901-907; \n\nDonadio, J.V., Jr., Torres, V.E., Velosa, J.A., Idiopathic membranous nephropathy: the natural history of untreated patients (1988) Kidney Int, 33, pp. 708-715; \n\nKida, H., Asamoto, T., Yokoyama, H., Long-term prognosis of membranous nephropathy (1986) Clin Nephrol, 25, pp. 64-69; \n\nRow, P.G., Cameron, J.S., Turner, D.R., Membranous nephropathy. Long-term follow-up and association with neoplasia (1975) Q J Med, 44, pp. 207-239; \n\nHepatitis B surface antigenemia in North American children with membranous glomerulonephropathy (1985) J Pediatr, 106, pp. 571-578; \n\nComparison of idiopathic and systemic lupus erythematosus-associated membranous glomerulonephropathy in children (1986) Am J Kidney Dis, 7, pp. 115-124; \n\nHabib, R., Kleinknecht, C., Gubler, M.C., Extramembranous glomerulonephritis in children: report of 50 cases (1973) J Pediatr, 82, pp. 754-766; \n\nYokoyama, H., Taguchi, T., Sugiyama, H., Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR) (2012) Clin Exp Nephrol, 16, pp. 557-563; \n\nHaas, M., Meehan, S.M., Karrison, T.G., Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997 (1997) Am J Kidney Dis, 30, pp. 621-631; \n\nKorbet, S.M., Genchi, R.M., Borok, R.Z., The racial prevalence of glomerular lesions in nephrotic adults (1996) Am J Kidney Dis, 27, pp. 647-651; \n\nHaas, M., Spargo, B.H., Coventry, S., Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study (1995) Am J Kidney Dis, 26, pp. 740-750; \n\nKitiyakara, C., Eggers, P., Kopp, J.B., Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States (2004) Am J Kidney Dis, 44, pp. 815-825; \n\nNair, R., Walker, P.D., Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA (2006) Kidney Int, 69, pp. 1455-1458; \n\nShemesh, O., Ross, J.C., Deen, W.M., Nature of the glomerular capillary injury in human membranous glomerulopathy (1986) J Clin Invest, 77, pp. 868-877; \n\nChen, A., Frank, R., Vento, S., Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome (2007) BMC Nephrol, 8, p. 11; \n\nBomback, A.S., Herlitz, L.C., Markowitz, G.S., Renal biopsy in the elderly and very elderly: useful or not? (2012) Adv Chronic Kidney Dis, 19, pp. 61-67; \n\nMoutzouris, D.A., Herlitz, L., Appel, G.B., Renal biopsy in the very elderly (2009) Clin J Am Soc Nephrol, 4, pp. 1073-1082; \n\nPackham, D.K., North, R.A., Fairley, K.F., Membranous glomerulonephritis and pregnancy (1987) Clin Nephrol, 28, pp. 56-64; \n\nEhrenreich, T., Churg, J., Pathology of Membranous Nephropathy (1968) Pathology Annual, pp. 389-433. , New York: Appleton-Century-Crofts; \n\nDanilewicz, M., Wagrowska-Danilewicz, M., Idiopathic membranous glomerulonephritis: a quantitative study of glomerular and interstitial lesions (1995) Pol J Pathol, 46, pp. 173-177; \n\nIkeda, S., Makino, H., Ota, Z., Alterations in glomerular extracellular matrix components in glomerulonephritis (1993) Nihon Jinzo Gakkai Shi, 35, pp. 941-947; \n\nKanahara, K., Yorioka, N., Ogawa, T., An immunohistochemical study of extracellular matrix components and integrins in human glomerular diseases (1994) Nihon Jinzo Gakkai Shi, 36, pp. 355-364; \n\nHughson, M.D., Johnson, K., Young, R.J., Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence (2002) Am J Kidney Dis, 39, pp. 679-688; \n\nLai, F.M., To, K.F., Wang, A.Y., Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities (2000) Mod Pathol, 13, pp. 166-172; \n\nJennette, J.C., Iskandar, S.S., Dalldorf, F.G., Pathologic differentiation between lupus and nonlupus membranous glomerulopathy (1983) Kidney Int, 24, pp. 377-385; \n\nStokes, M.B., Alpers, C.E., Combined membranous nephropathy and IgA nephropathy (1998) Am J Kidney Dis, 32, pp. 649-656; \n\nJennette, J.C., Newman, W.J., Diaz-Buxo, J.A., Overlapping IgA and membranous nephropathy (1987) Am J Clin Pathol, 88, pp. 74-78; \n\nHonig, C., Mouradian, J.A., Montoliu, J., Mesangial electron-dense deposits in membranous nephropathy (1980) Lab Invest, 42, pp. 427-432; \n\nBurkholder, P.M., Marchand, A., Krueger, R.P., Mixed membranous and proliferative glomerulonephritis. A correlative light, immunofluorescence, and electron microscopic study (1970) Lab Invest, 23, pp. 459-479; \n\nLefaucheur, C., Stengel, B., Nochy, D., Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association (2006) Kidney Int, 70, pp. 1510-1517; \n\nGupta, R., Sharma, A., Mahanta, P.J., Focal segmental glomerulosclerosis in idiopathic membranous glomerulonephritis: A clinico-pathological and stereological study (2010) Nephrol Dial Transplant, 25, pp. 444-449; \n\nHeeringa, S.F., Branten, A.J., Deegens, J.K., Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy (2007) Nephrol Dial Transplant, 22, pp. 2201-2207; \n\nDumoulin, A., Hill, G.S., Montseny, J.J., Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis (2003) Am J Kidney Dis, 41, pp. 38-48; \n\nWakai, S., Magil, A.B., Focal glomerulosclerosis in idiopathic membranous glomerulonephritis (1992) Kidney Int, 41, pp. 428-434; \n\nHowie, A.J., Changes at the glomerular tip: a feature of membranous nephropathy and other disorders associated with proteinuria (1986) J Pathol, 150, pp. 13-20; \n\nKambham, N., Markowitz, G.S., Slater, L.M., An 18-year-old female with acute onset of nephrotic syndrome (2000) Am J Kidney Dis, 36, pp. 441-446; \n\nMagil, A.B., Tubulointerstitial lesions in human membranous glomerulonephritis: relationship to proteinuria (1995) Am J Kidney Dis, 25, pp. 375-379; \n\nWehrmann, M., Bohle, A., Bogenschutz, O., Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes (1989) Clin Nephrol, 31, pp. 67-76; \n\nAlexopoulos, E., Seron, D., Hartley, R.B., Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrates (1989) Am J Kidney Dis, 13, pp. 404-412; \n\nKurihara, I., Saito, T., Soma, J., Clinicopathological characteristics of interstitial foam cells in membranous nephropathy (1999) Kidney Int Suppl, 71, pp. S144-S146; \n\nChampion de Crespigny, P.J., Becker, G.J., Ihle, B.U., Renal failure and nephrotic syndrome associated with sulindac (1988) Clin Nephrol, 30, pp. 52-55; \n\nRevai, T., Harmos, G., Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac (1999) Wien Klin Wochenschr, 111, pp. 523-524; \n\nRosenmann, E., Pollak, V.E., Pirani, C.L., Renal vein thrombosis in the adult: a clinical and pathologic study based on renal biopsies (1968) Medicine, 47, pp. 269-335; \n\nBertani, T., Appel, G.B., D'Agati, V., Focal segmental membranous glomerulonephropathy associated with other glomerular diseases (1983) Am J Kidney Dis, 2, pp. 439-448; \n\nGartner, H.V., Fischbach, H., Wehner, H., Comparison of clinical and morphological features of peri-(epi-extra) membranous glomerulonephritis (1974) Nephron, 13, pp. 288-301; \n\nGuiard, E., Karras, A., Plaisier, E., Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab (2011) Clin J Am Soc Nephrol, 6, pp. 1609-1616; \n\nNasr, S.H., Satoskar, A., Markowitz, G.S., Proliferative glomerulonephritis with monoclonal IgG deposits (2009) J Am Soc Nephrol, 20, pp. 2055-2064; \n\nSigal, L.H., Basic science for the clinician 58: IgG subclasses (2012) J Clin Rheumatol, 18, pp. 316-318; \n\nAalberse, R.C., Schuurman, J., IgG4 breaking the rules (2002) Immunology, 105, pp. 9-19; \n\nOhtani, H., Wakui, H., Komatsuda, A., Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy (2004) Nephrol Dial Transplant, 19, pp. 574-579; \n\nDoi, T., Mayumi, M., Kanatsu, K., Distribution of IgG subclasses in membranous nephropathy (1984) Clin Exp Immunol, 58, pp. 57-62; \n\nHaas, M., IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies (1994) Am J Kidney Dis, 23, pp. 358-364; \n\nImai, H., Hamai, K., Komatsuda, A., IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis (1997) Kidney Int, 51, pp. 270-276; \n\nKuroki, A., Shibata, T., Honda, H., Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy (2002) Intern Med, 41, pp. 936-942; \n\nNoel, L.H., Aucouturier, P., Monteiro, R.C., Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis (1988) Clin Immunol Immunopathol, 46, pp. 186-194; \n\nMakker, S.P., Tramontano, A., Idiopathic membranous nephropathy: an autoimmune disease (2011) Semin Nephrol, 31, pp. 333-340; \n\nMa, H., Beck, L.P., Salant, D.J., Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 antibodies active the lectin complement pathway (2011) J Am Soc Nephrol, 22, p. 62A; \n\nHuang, C.C., Lehman, A., Albawardi, A., IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression (2013) Mod Pathol, 26, pp. 799-805; \n\nKearney, N., Podolak, J., Matsumura, L., Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts (2011) Transplant Proc, 43, pp. 3743-3746; \n\nLi, S.J., Zhang, S.H., Chen, H.P., Mercury-induced membranous nephropathy: clinical and pathological features (2010) Clin J Am Soc Nephrol, 5, pp. 439-444; \n\nZuniga, R., Markowitz, G.S., Arkachaisri, T., Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles (2003) Arthritis Rheum, 48, pp. 460-470; \n\nDebiec, H., Ronco, P., PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy (2011) N Engl J Med, 364, pp. 689-690; \n\nHoxha, E., Kneissler, U., Stege, G., Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy (2012) Kidney Int, 82, pp. 797-804; \n\nLarsen, C.P., Messias, N.C., Silva, F.G., Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies (2012) Mod Pathol, 26 (5), pp. 709-715; \n\nSvobodova, B., Honsova, E., Ronco, P., Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy (2012) Nephrol Dial Transplant, 28 (7), pp. 1839-1844; \n\nLehman, D.H., Wilson, C.B., Dixon, F.J., Extraglomerular immunoglobulin deposits in human nephritis (1975) Am J Med, 58, pp. 765-796; \n\nMarkowitz, G.S., Kambham, N., Maruyama, S., Membranous glomerulopathy with Bowman's capsular and tubular basement membrane deposits (2000) Clin Nephrol, 54, pp. 478-486; \n\nIvanyi, B., Haszon, I., Endreffy, E., Childhood membranous nephropathy, circulating antibodies to the 58-kD TIN antigen, and anti-tubular basement membrane nephritis: an 11-year follow-up (1998) Am J Kidney Dis, 32, pp. 1068-1074; \n\nMarkowitz, G.S., Seigle, R.L., D'Agati, V.D., Three-year-old boy with partial Fanconi syndrome (1999) Am J Kidney Dis, 34, pp. 184-188; \n\nTay, A.H., Ren, E.C., Murugasu, B., Membranous nephropathy with anti-tubular basement membrane antibody may be X-linked (2000) Pediatr Nephrol, 14, pp. 747-753; \n\nCrary, G.S., Katz, A., Fish, A.J., Role of a basement membrane glycoprotein in anti-tubular basement membrane nephritis (1993) Kidney Int, 43, pp. 140-146; \n\nNelson, T.R., Charonis, A.S., McIvor, R.S., Identification of a cDNA encoding tubulointerstitial nephritis antigen (1995) J Biol Chem, 270, pp. 16265-16270; \n\nKalfa, T.A., Thull, J.D., Butkowski, R.J., Tubulointerstitial nephritis antigen interacts with laminin and type IV collagen and promotes cell adhesion (1994) J Biol Chem, 269, pp. 1654-1659; \n\nDoi, T., Kanatsu, K., Nagai, H., An overlapping syndrome of IgA nephropathy and membranous nephropathy? (1983) Nephron, 35, pp. 24-30; \n\nCybulsky, A.V., Membranous nephropathy (2011) Contrib Nephrol, 169, pp. 107-125; \n\nBonsib, S.M., Scanning electron microscopy of acellular glomeruli in nephrotic syndrome (1985) Kidney Int, 27, pp. 678-684; \n\nTornroth, T., Skrifvars, B., The development and resolution of glomerular basement membrane changes associated with subepithelial immune deposits (1975) Am J Pathol, 79, pp. 219-236; \n\nHonkanen, E., Tornroth, T., Gronhagen-Riska, C., Natural history, clinical course and morphological evolution of membranous nephropathy (1992) Nephrol Dial Transplant, 7, pp. 35-41; \n\nForland, M., Spargo, B.H., Clinicopathological correlations in idiopathic nephrotic syndrome with membranous nephropathy (1969) Nephron, 6, pp. 498-525; \n\nGartner, H.V., Membranous (peri-, epi-, extramembranous) glomerulonephritis. Prototype of an immune complex glomerulonephritis. A clinical morphological study (1980) Veroff Pathol, 113, pp. 1-136; \n\nGluck, M.C., Gallo, G., Lowenstein, J., Membranous glomerulonephritis. Evolution of clinical and pathologic features (1973) Ann Intern Med, 78, pp. 1-12; \n\nRastogi, S.P., Hart-Mercer, J., Kerr, D.N., Idiopathic membranous glomerulonephritis in adults: remission following steroid therapy (1969) Q J Med, 38, pp. 335-350; \n\nYoshimoto, K., Yokoyama, H., Wada, T., Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy (2004) Kidney Int, 65, pp. 148-153; \n\nGaffney, E.F., Alexander, R.W., Donnelly, W.H., Segmental membranous glomerulonephritis (1982) Arch Pathol Lab Med, 106, pp. 409-412; \n\nObana, M., Nakanishi, K., Sako, M., Segmental membranous glomerulonephritis in children: comparison with global membranous glomerulonephritis (2006) Clin J Am Soc Nephrol, 1, pp. 723-729; \n\nYamamoto, S., Inaba, S., Yoshida, R., Clinicopathological characteristics of the focal and segmental form of idiopathic membranous nephropathy: comparison with the typical form of this disease (1997) Acta Paediatr Jpn, 39, pp. 349-353; \n\nNasr, S.H., Said, S.M., Valeri, A.M., Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis (2009) Clin J Am Soc Nephrol, 4, pp. 299-308; \n\nBridoux, F., Hugue, V., Coldefy, O., Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features (2002) Kidney Int, 62, pp. 1764-1775; \n\nKowalewska, J., Smith, K.D., Hudkins, K.L., Membranous glomerulopathy with spherules: an uncommon variant with obscure pathogenesis (2006) Am J Kidney Dis, 47, pp. 983-992; \n\nMuller-Hocker, J., Weiss, M., Sitter, T., Fibrillary glomerulonephritis mimicking membranous nephropathy-a diagnostic pitfall (2009) Pathol Res Pract, 205, pp. 265-271; \n\nNasr, S.H., Fidler, M.E., Cornell, L.D., Immunotactoid glomerulopathy: clinicopathologic and proteomic study (2012) Nephrol Dial Transplant, 27, pp. 4137-4146; \n\nNasr, S.H., Valeri, A.M., Cornell, L.D., Fibrillary glomerulonephritis: a report of 66 cases from a single institution (2011) Clin J Am Soc Nephrol, 6, pp. 775-784; \n\nRosenstock, J.L., Markowitz, G.S., Valeri, A.M., Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features (2003) Kidney Int, 63, pp. 1450-1461; \n\nJoh, K., Makino, H., Proposal of podocytic infolding glomerulopathy as a new disease entity (2008) Clin Exp Nephrol, 12, pp. 417-418; \n\nJoh, K., Taguchi, T., Shigematsu, H., Proposal of podocytic infolding glomerulopathy as a new disease entity: a review of 25 cases from nationwide research in Japan (2008) Clin Exp Nephrol, 12, pp. 421-431; \n\nNomura, S., Inoue-Kiyohara, M., Oosugi, K., Unusual glomerulopathy with aggregated subepithelial microspheric particles resembling membranous nephropathy: a variant of glomerulopathy associated with podocytic infolding? (2008) Clin Exp Nephrol, 12, pp. 513-517; \n\nShearn, M.A., Biava, C., Hopper, J., Jr., Mesangial deposits (by electron microscopy) in idiopathic membranous glomerulonephritis (1979) N Engl J Med, 301, p. 212; \n\nKlassen, J., Elwood, C., Grossberg, A.L., Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis (1974) N Engl J Med, 290, pp. 1340-1344; \n\nPettersson, E., Tornroth, T., Miettinen, A., Simultaneous anti-glomerular basement membrane and membranous glomerulonephritis: case report and literature review (1984) Clin Immunol Immunopathol, 31, pp. 171-180; \n\nBasford, A.W., Lewis, J., Dwyer, J.P., Membranous nephropathy with crescents (2011) J Am Soc Nephrol, 22, pp. 1804-1808; \n\nNasr, S.H., Ilamathi, M.E., Markowitz, G.S., A dual pattern of immunofluorescence positivity (2003) Am J Kidney Dis, 42, pp. 419-426; \n\nIcard, P., Pelletier, L., Vial, M.C., Evidence for a role of antilaminin-producing B cell clones that escape tolerance in the pathogenesis of HgCl2-induced membranous glomerulopathy (1993) Nephrol Dial Transplant, 8, pp. 122-127; \n\nGaber, L.W., Wall, B.M., Cooke, C.R., Coexistence of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and membranous glomerulopathy (1993) Am J Clin Pathol, 99, pp. 211-215; \n\nTse, W.Y., Howie, A.J., Adu, D., Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases (1997) Nephrol Dial Transplant, 12, pp. 1017-1027; \n\nHeymann, W., Hackel, D.B., Harwood, S., Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions (1959) Proc Soc Exp Biol Med, 100, pp. 660-664; \n\nFeenstra, K., van den Lee, R., Greben, H.A., Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. I. The natural history: a histologic and immunohistologic study at the light microscopic and the ultrastructural level (1975) Lab Invest, 32, pp. 235-242; \n\nEdgington, T.S., Glassock, R.J., Dixon, F.J., Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen (1968) J Exp Med, 127, pp. 555-572; \n\nBarabas, A.Z., Lannigan, R., Induction of an autologous immune-complex glomerulonephritis in the rat by IV injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephritis (1974) Brit J Exp Pathol, 55, pp. 47-55; \n\nKerjaschki, D., Molecular pathogenesis of membranous nephropathy (1992) Kidney Int, 41, pp. 1090-1105; \n\nCouser, W.G., Steinmuller, D.R., Stilmant, M.M., Experimental glomerulonephritis in the isolated perfused rat kidney (1978) J Clin Invest, 62, pp. 1275-1287; \n\nVan Damme, B.J., Fleuren, G.J., Bakker, W.W., Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis (1978) Lab Invest, 38, pp. 502-510; \n\nKerjaschki, D., Farquhar, M.G., The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border (1982) Proc Natl Acad Sci U S A, 79, pp. 5557-5561; \n\nKerjaschki, D., Farquhar, M.G., Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats (1983) J Exp Med, 157, pp. 667-686; \n\nHjalm, G., Murray, E., Crumley, G., Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties (1996) Eur J Biocehm, 239, pp. 132-137; \n\nSaito, A., Pietromonaco, S., Loo, A.K., Complete cloning and sequencing of rat gp330/\"megalin,\" a distinctive member of the low density lipoprotein receptor gene family (1994) Proc Natl Acad Sci U S A, 91, pp. 9725-9729; \n\nKerjaschki, D., Exner, M., Ullrich, R., Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis (1997) J Clin Invest, 100, pp. 2303-2309; \n\nExner, M., Susani, M., Witztum, J.L., Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis (1996) Am J Pathol, 149, pp. 1313-1320; \n\nCouser, W.G., Membranous nephropathy: a long road but well traveled (2005) J Am Soc Nephrol, 16, pp. 1184-1187; \n\nBaker, P.J., Ochi, R.F., Schulze, M., Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats (1989) Am J Pathol, 135, pp. 185-194; \n\nCunningham, P.N., Quigg, R.J., Contrasting roles of complement activation and its regulation in membranous nephropathy (2005) J Am Soc Nephrol, 16, pp. 1214-1222; \n\nCybulsky, A.V., Rennke, H.G., Feintzeig, I.D., Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy (1986) J Clin Invest, 77, pp. 1096-1107; \n\nNangaku, M., Shankland, S.J., Couser, W.G., Cellular response to injury in membranous nephropathy (2005) J Am Soc Nephrol, 16, pp. 1195-1204; \n\nQuigg, R.J., Holers, V.M., Morgan, B.P., Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis (1995) J Immunol, 154, pp. 3437-3443; \n\nSalant, D.J., Belok, S., Madaio, M.P., A new role for complement in experimental membranous nephropathy in rats (1980) J Clin Invest, 66, pp. 1339-1350; \n\nSaran, A.M., Yuan, H., Takeuchi, E., Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy (2003) Kidney Int, 64, pp. 2072-2078; \n\nSchiller, B., He, C., Salant, D.J., Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis (1998) J Exp Med, 188, pp. 1353-1358; \n\nYuan, H., Takeuchi, E., Taylor, G.A., Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy (2002) J Am Soc Nephrol, 13, pp. 946-956; \n\nHsu, S.I., Couser, W.G., Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors? (2003) J Am Soc Nephrol, 14, pp. S186-S191; \n\nDebiec, H., Guigonis, V., Mougenot, B., Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies (2002) N Engl J Med, 346, pp. 2053-2060; \n\nErdos, E.G., Skidgel, R.A., Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones (1989) FASEB J, 3, pp. 145-151; \n\nLetarte, M., Vera, S., Tran, R., Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase (1988) J Exp Med, 168, pp. 1247-1253; \n\nTurner, A.J., Tanzawa, K., Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX (1997) FASEB J, 11, pp. 355-364; \n\nDebiec, H., Nauta, J., Coulet, F., Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies (2004) Lancet, 364, pp. 1252-1259; \n\nHanasaki, K., Mammalian phospholipase A2: phospholipase A2 receptor (2004) Biol Pharm Bull, 27, pp. 1165-1167; \n\nBeck, L.H., Jr., Fervenza, F.C., Beck, D.M., Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy (2011) J Am Soc Nephrol, 22, pp. 1543-1550; \n\nBlosser, C.D., Ayalon, R., Nair, R., Very early recurrence of anti-Phospholipase A2 receptor-positive membranous nephropathy after transplantation (2012) Am J Transplant, 12, pp. 1637-1642; \n\nDebiec, H., Martin, L., Jouanneau, C., Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy (2011) Am J Transplant, 11, pp. 2144-2152; \n\nHofstra, J.M., Beck, L.H., Jr., Beck, D.M., Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy (2011) Clin J Am Soc Nephrol, 6, pp. 1286-1291; \n\nQin, W., Beck, L.H., Jr., Zeng, C., Anti-phospholipase A2 receptor antibody in membranous nephropathy (2011) J Am Soc Nephrol, 22, pp. 1137-1143; \n\nStahl, R., Hoxha, E., Fechner, K., PLA2R autoantibodies and recurrent membranous nephropathy after transplantation (2010) N Engl J Med, 363, pp. 496-498; \n\nBeck, L.H., Jr., Salant, D.J., Membranous nephropathy: recent travels and new roads ahead (2010) Kidney Int, 77, pp. 765-770; \n\nCouser, W.G., Basic and translational concepts of immune-mediated glomerular diseases (2012) J Am Soc Nephrol, 23, pp. 381-399; \n\nBruschi, M., Carnevali, M.L., Murtas, C., Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens (2011) J Proteomics, 74, pp. 2008-2017; \n\nMurtas, C., Bruschi, M., Candiano, G., Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy (2012) Clin J Am Soc Nephrol, 7, pp. 1394-1400; \n\nPrunotto, M., Carnevali, M.L., Candiano, G., Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 (2010) J Am Soc Nephrol, 21, pp. 507-519; \n\nHuang, X., Qin, W., Zhang, M., Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy (2013) Am J Med Sci, 346 (1), pp. 32-37; \n\nGunnarsson, I., Schlumberger, W., Ronnelid, J., Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis (2012) Am J Kidney Dis, 59, pp. 585-586; \n\nKim, S., Chin, H.J., Na, K.Y., Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy (2011) Nephron Clin Pract, 117, pp. c253-c258; \n\nLiu, Y.H., Chen, C.H., Chen, S.Y., Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan (2010) J Biomed Sci, 17, p. 81; \n\nStanescu, H.C., Arcos-Burgos, M., Medlar, A., Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy (2011) N Engl J Med, 364, pp. 616-626; \n\nKain, R., Exner, M., Brandes, R., Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis (2008) Nat Med, 14, pp. 1088-1096; \n\nCouser, W.G., Wagonfeld, J.B., Spargo, B.H., Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma (1974) Am J Med, 57, pp. 962-970; \n\nLai, F.M., Lai, K.N., Tam, J.S., Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens (1994) Am J Surg Pathol, 18, pp. 175-186; \n\nDebiec, H., Lefeu, F., Kemper, M.J., Early-childhood membranous nephropathy due to cationic bovine serum albumin (2011) N Engl J Med, 364, pp. 2101-2110; \n\nBorder, W.A., Ward, H.J., Kamil, E.S., Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen (1982) J Clin Invest, 69, pp. 451-461; \n\nHunley, T.E., Corzo, D., Dudek, M., Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease (2004) Pediatrics, 114, pp. e532-e535; \n\nHorvatic, I., Ljubanovic, D.G., Bulimbasic, S., Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy (2012) Pathol Res Pract, 208, pp. 662-667; \n\nAbbate, M., Zoja, C., Remuzzi, G., How does proteinuria cause progressive renal damage (2006) J Am Soc Nephrol, 17, pp. 2974-2984; \n\nStrutz, F.M., EMT and proteinuria as progression factors (2009) Kidney Int, 75, pp. 475-481; \n\nZoja, C., Donadelli, R., Colleoni, S., Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation (1998) Kidney Int, 53, pp. 1608-1615; \n\nWang, Y., Chen, J., Chen, L., Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein (1997) J Am Soc Nephrol, 8, pp. 1537-1545; \n\nIwano, M., Plieth, D., Danoff, T.M., Evidence that fibroblasts derive from epithelium during tissue fibrosis (2002) J Clin Invest, 110, pp. 341-350; \n\nLiu, Y., New insights into epithelial-mesenchymal transition in kidney fibrosis (2010) J Am Soc Nephrol, 21, pp. 212-222; \n\nMezzano, S.A., Barria, M., Droguett, M.A., Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease (2001) Kidney Int, 60, pp. 1366-1377; \n\nMezzano, S.A., Droguett, M.A., Burgos, M.E., Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy (2000) Kidney Int, 57, pp. 147-158; \n\nRandomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy (1997) Lancet, 349, pp. 1857-1863; \n\nAnders, D., Thoenes, W., Basement membrane-changes in membranoproliferative glomerulonephritis: a light and electron microscopic study (1975) Virchows Arch A Pathol Anat Histol, 369, pp. 87-109; \n\nStrife, C.F., McEnery, P.T., McAdams, A.J., Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane (1977) Clin Nephrol, 7, pp. 65-72; \n\nCameron, J.S., Pathogenesis and treatment of membranous nephropathy (1979) Kidney Int, 15, pp. 88-103; \n\nNoel, L.H., Zanetti, M., Droz, D., Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients (1979) Am J Med, 66, pp. 82-90; \n\nSchieppati, A., Mosconi, L., Perna, A., Prognosis of untreated patients with idiopathic membranous nephropathy (1993) N Engl J Med, 329, pp. 85-89; \n\nCattran, D.C., Delmore, T., Roscoe, J., A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy (1989) N Engl J Med, 320, pp. 210-215; \n\nCattran, D.C., Membranous nephropathy: quo vadis? (2002) Kidney Int, 61, pp. 349-350; \n\nMarx, B.E., Marx, M., Prediction in idiopathic membranous nephropathy (1999) Kidney Int, 56, pp. 666-673; \n\nShiiki, H., Saito, T., Nishitani, Y., Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan (2004) Kidney Int, 65, pp. 1400-1407; \n\nToth, T., Takebayashi, S., Factors contributing to the outcome in 100 adult patients with idiopathic membranous glomerulonephritis (1994) Int Urol Nephrol, 26, pp. 93-106; \n\nWu, Q., Jinde, K., Nishina, M., Analysis of prognostic predictors in idiopathic membranous nephropathy (2001) Am J Kidney Dis, 37, pp. 380-387; \n\nPonticelli, C., Zucchelli, P., Passerini, P., Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy (1992) N Engl J Med, 327, pp. 599-603. , The Italian Idiopathic Membranous Nephropathy Treatment Study Group; \n\nDoi, T., Kanatsu, K., Nagai, H., Demonstration of C3d deposits in membranous nephropathy (1984) Nephron, 37, pp. 232-235; \n\nBone, J.M., Rustom, R., Williams, P.S., 'Progressive' versus 'indolent' idiopathic membranous glomerulonephritis (1997) QJM, 90, pp. 699-706; \n\nPei, Y., Cattran, D., Greenwood, C., Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis (1992) Kidney Int, 42, pp. 960-966; \n\nDavison, A.M., Cameron, J.S., Kerr, D.N., The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults (1984) Clin Nephrol, 22, pp. 61-67; \n\nHladunewich, M.A., Troyanov, S., Calafati, J., Metropolitan Toronto Glomerulonephritis R: The natural history of the non-nephrotic membranous nephropathy patient (2009) Clin J Am Soc Nephrol, 4, pp. 1417-1422; \n\nPolanco, N., Gutierrez, E., Covarsi, A., Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy (2010) J Am Soc Nephrol, 21, pp. 697-704; \n\nTroyanov, S., Wall, C.A., Miller, J.A., Idiopathic membranous nephropathy: definition and relevance of a partial remission (2004) Kidney Int, 66, pp. 1199-1205. , Toronto Glomerulonephritis Registry G; \n\nSegal, P.E., Choi, M.J., Recent advances and prognosis in idiopathic membranous nephropathy (2012) Adv Chronic Kidney Dis, 19, pp. 114-119; \n\nHopper, J., Jr., Trew, P.A., Biava, C.G., Membranous nephropathy: its relative benignity in women (1981) Nephron, 29, pp. 18-24; \n\nOlbing, H., Greifer, I., Bennett, B.P., Idiopathic membranous nephropathy in children (1973) Kidney Int, 3, pp. 381-390; \n\nBranten, A.J., du Buf-Vereijken, P.W., Klasen, I.S., Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study (2005) J Am Soc Nephrol, 16, pp. 169-174; \n\nReichert, L.J., Koene, R.A., Wetzels, J.F., Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy (1995) J Am Soc Nephrol, 6, pp. 1666-1669; \n\nReichert, L.J., Koene, R.A., Wetzels, J.F., Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy (1997) Clin Nephrol, 48, pp. 79-84; \n\nKanigicherla, D., Gummadova, J., McKenzie, E.A., Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy (2013) Kidney Int, 83, pp. 940-948; \n\nHerrmann, S.M., Sethi, S., Fervenza, F.C., Membranous nephropathy: the start of a paradigm shift (2012) Curr Opin Nephrol Hypertens, 21, pp. 203-210; \n\nHofstra, J.M., Fervenza, F.C., Wetzels, J.F., Treatment of idiopathic membranous nephropathy (2013) Nat Rev Nephrol, 9 (8), pp. 443-458; \n\nPonticelli, C., Glassock, R.J., Glomerular diseases: membranous nephropathy-a modern view (2014) Clin J Am Soc Nephrol, 9 (3), pp. 609-616; \n\nWaldman, M., Austin, H.A., III, Treatment of idiopathic membranous nephropathy (2012) J Am Soc Nephrol, 23, pp. 1617-1630; \n\nJafar, T.H., Schmid, C.H., Landa, M., Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data (2001) Ann Intern Med, 135, pp. 73-87; \n\nRuggenenti, P., Mosconi, L., Vendramin, G., ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome (2000) Am J Kidney Dis, 35, pp. 381-391; \n\nNickolas, T.L., Radhakrishnan, J., Appel, G.B., Hyperlipidemia and thrombotic complications in patients with membranous nephropathy (2003) Semin Nephrol, 23, pp. 406-411; \n\nRayner, B.L., Byrne, M.J., van Zyl Smit, R., A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone (1996) Clin Nephrol, 46, pp. 219-224; \n\nGiordano, M., De Feo, P., Lucidi, P., Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients (2001) Kidney Int, 60, pp. 235-242; \n\nLionaki, S., Derebail, V.K., Hogan, S.L., Venous thromboembolism in patients with membranous nephropathy (2012) Clin J Am Soc Nephrol, 7, pp. 43-51; \n\nHogan, S.L., Muller, K.E., Jennette, J.C., A review of therapeutic studies of idiopathic membranous glomerulopathy (1995) Am J Kidney Dis, 25, pp. 862-875; \n\nPonticelli, C., Zucchelli, P., Imbasciati, E., Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy (1984) N Engl J Med, 310, pp. 946-950; \n\nPonticelli, C., Zucchelli, P., Passerini, P., A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy (1989) N Engl J Med, 320, pp. 8-13; \n\nPonticelli, C., Zucchelli, P., Passerini, P., A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy (1995) Kidney Int, 48, pp. 1600-1604; \n\nChen, Y., Schieppati, A., Cai, G., Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials (2013) Clin J Am Soc Nephrol, 8, pp. 787-796; \n\nCattran, D.C., Appel, G.B., Hebert, L.A., Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial (2001) Kidney Int, 59, pp. 1484-1490; \n\nPraga, M., Barrio, V., Juarez, G.F., Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial (2007) Kidney Int, 71, pp. 924-930; \n\nHowman, A., Chapman, T.L., Langdon, M.M., Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial (2013) Lancet, 381, pp. 744-751; \n\nRadhakrishnan, J., Cattran, D.C., The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient (2012) Kidney Int, 82, pp. 840-856; \n\nBomback, A.S., Derebail, V.K., McGregor, J.G., Rituximab therapy for membranous nephropathy: a systematic review (2009) Clin J Am Soc Nephrol, 4, pp. 734-744; \n\nFervenza, F.C., Abraham, R.S., Erickson, S.B., Rituximab therapy in idiopathic membranous nephropathy: a 2-year study (2010) Clin J Am Soc Nephrol, 5, pp. 2188-2198; \n\nFervenza, F.C., Cosio, F.G., Erickson, S.B., Rituximab treatment of idiopathic membranous nephropathy (2008) Kidney Int, 73, pp. 117-125; \n\nRemuzzi, G., Chiurchiu, C., Abbate, M., Rituximab for idiopathic membranous nephropathy (2002) Lancet, 360, pp. 923-924; \n\nBranten, A.J., du Buf-Vereijken, P.W., Vervloet, M., Mycophenolate mofetil in idiopathic membranous nephropathy: a clinical trial with comparison to a historic control group treated with cyclophosphamide (2007) Am J Kidney Dis, 50, pp. 248-256; \n\nBomback, A.S., Tumlin, J.A., Baranski, J., Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel (2011) Drug Des Devel Ther, 5, pp. 147-153; \n\nPonticelli, C., Passerini, P., Salvadori, M., A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy (2006) Am J Kidney Dis, 47, pp. 233-240; \n\nMarkowitz, G.S., Membranous glomerulopathy: emphasis on secondary forms and disease variants (2001) Adv Anat Pathol, 8, pp. 119-125; \n\nKleinknecht, C., Levy, M., Gagnadoux, M.F., Membranous glomerulonephritis with extra-renal disorders in children (1979) Medicine, 58, pp. 219-228; \n\nBurstein, D.M., Korbet, S.M., Schwartz, M.M., Membranous glomerulonephritis and malignancy (1993) Am J Kidney Dis, 22, pp. 5-10; \n\nRihova, Z., Honsova, E., Merta, M., Secondary membranous nephropathy-one center experience (2005) Ren Fail, 27, pp. 397-402; \n\nBjorneklett, R., Vikse, B.E., Svarstad, E., Long-term risk of cancer in membranous nephropathy patients (2007) Am J Kidney Dis, 50, pp. 396-403; \n\nHill, G.S., Drug-associated glomerulopathies (1986) Toxicol Pathol, 14, pp. 37-44; \n\nIzzedine, H., Launay-Vacher, V., Bourry, E., Drug-induced glomerulopathies (2006) Expert Opin Drug Saf, 5, pp. 95-106; \n\nEllman, P., Lawrence, J.S., Gold Therapy in Rheumatoid Arthritis (1938) Postgrad Med J, 14, pp. 275-287; \n\nKatz, W.A., Blodgett, R.C., Jr., Pietrusko, R.G., Proteinuria in gold-treated rheumatoid arthritis (1984) Ann Intern Med, 101, pp. 176-179; \n\nSilverberg, D.S., Kidd, E.G., Shnitka, T.K., Gold nephropathy. A clinical and pathologic study (1970) Arthritis Rheum, 13, pp. 812-825; \n\nHorton, R.J., Comparative safety and efficacy of auranofin and parenteral gold compounds: a review (1983) Scand J Rheumatol Suppl, 51, pp. 100-110; \n\nTozman, E.C., Gottlieb, N.L., Adverse reactions with oral and parenteral gold preparations (1987) Med Toxicol, 2, pp. 177-189; \n\nWard, J.R., Williams, H.J., Egger, M.J., Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial (1983) Arthritis Rheum, 26, pp. 1303-1315; \n\nHall, C.L., Fothergill, N.J., Blackwell, M.M., The natural course of gold nephropathy: long term study of 21 patients (1987) Br Med J (Clin Res Ed), 295, pp. 745-748; \n\nFrancis, K.L., Jenis, E.H., Jensen, G.E., Gold-associated nephropathy (1984) Arch Pathol Lab Med, 108, pp. 234-238; \n\nTonroth, T., Skrifvars, B., Gold nephropathy prototype of membranous glomerulonephritis (1974) Am J Pathol, 75, pp. 573-590; \n\nBrun, C., Olsen, S., Raaschou, F., The localization of gold in the human kidney following chrysotherapy: a biopsy study (1964) Nephron, 1, pp. 265-276; \n\nAinsworth, S.K., Swain, R.P., Watabe, N., Gold nephropathy. Ultrastructural, fluorescent, and energy-dispersive x-ray microanalysis study (1981) Arch Pathol Lab Med, 105, pp. 373-378; \n\nNagi, A.H., Alexander, F., Barabas, A.Z., Gold nephropathy in rats-light and electron microscopic studies (1971) Exp Mol Pathol, 15, pp. 354-362; \n\nHonkanen, E., Tornroth, T., Pettersson, E., Membranous glomerulonephritis in rheumatoid arthritis not related to gold or D-penicillamine therapy: a report of four cases and review of the literature (1987) Clin Nephrol, 27, pp. 87-93; \n\nSamuels, B., Lee, J.C., Engleman, E.P., Membranous nephropathy in patients with rheumatoid arthritis: relationship to gold therapy (1978) Medicine, 57, pp. 319-327; \n\nDay, A.T., Golding, J.R., Lee, P.N., Penicillamine in rheumatoid disease: a long-term study (1974) Br Med J, 1, pp. 180-183; \n\nCrawhall, J.C., Proteinuria in D-penicillamine-treated rheumatoid arthritis (1981) J Rheumatol Suppl, 7, pp. 161-163; \n\nStockman, A., Richter, D., Barraclough, D., Difficulties in the use of D-penicillamine in the treatment of rheumatoid arthritis (1979) Aust N Z J Med, 9, pp. 495-503; \n\nDische, F.E., Swinson, D.R., Hamilton, E.B., Immunopathology of penicillamine-induced glomerular disease (1984) J Rheumatol, 11, pp. 584-585; \n\nHall, C.L., Jawad, S., Harrison, P.R., Natural course of penicillamine nephropathy: a long term study of 33 patients (1988) Br Med J (Clin Res Ed), 296, pp. 1083-1086; \n\nControlled trial of D(-)penicillamine in severe rheumatoid arthritis (1973) Lancet, 1, pp. 275-280; \n\nLachmann, P.J., Nephrotic syndrome from penicillamine (1968) Postgrad Med J, pp. 23-27; \n\nNagahama, K., Matsushita, H., Hara, M., Bucillamine induces membranous glomerulonephritis (2002) Am J Kidney Dis, 39, pp. 706-712; \n\nIsozaki, T., Kimura, M., Ikegaya, N., Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and review of the literature (1992) Clin Investig, 70, pp. 1036-1042; \n\nKikuchi, M., Saeki, T., Ito, S., [Clinicopathological evaluation and treatment of bucillamine induced membranous nephropathy] (1993) Ryumachi [Rheumatism], 33, pp. 215-222; \n\nObayashi, M., Uzu, T., Harada, T., Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis (2003) Clin Exp Nephrol, 7, pp. 275-278; \n\nYoshida, A., Morozumi, K., Suganuma, T., Clinicopathological findings of bucillamine-induced nephrotic syndrome in patients with rheumatoid arthritis (1991) Am J Nephrol, 11, pp. 284-288; \n\nLewis, E.J., Proteinuria and abnormalities of the renal glomerulus in patients with hypertension (1982) Clin Exp Pharmacol Physiol Suppl, 7, pp. 105-115; \n\nRosendorff, C., Captopril-an overview (1982) S Afr Med J, 62, pp. 593-599; \n\nCase, D.B., Atlas, S.A., Mouradian, J.A., Proteinuria during long-term captopril therapy (1980) JAMA, 244, pp. 346-349; \n\nHoorntje, S.J., Donker, A.J., Prins, E.J., Membranous glomerulopathy in a patient on captopril (1980) Acta Med Scand, 208, pp. 325-329; \n\nHoorntje, S.J., Kallenberg, C.G., Weening, J.J., Immune-complex glomerulopathy in patients treated with captopril (1980) Lancet, 1, pp. 1212-1215; \n\nSturgill, B.C., Shearlock, K.T., Membranous glomerulopathy and nephrotic syndrome after captopril therapy (1983) JAMA, 250, pp. 2343-2345; \n\nTextor, S.C., Gephardt, G.N., Bravo, E.L., Membranous glomerulopathy associated with captopril therapy (1983) Am J Med, 74, pp. 705-712; \n\nJaffe, I.A., Adverse effects profile of sulfhydryl compounds in man (1986) Am J Med, 80, pp. 471-476; \n\nCounter, S.A., Buchanan, L.H., Mercury exposure in children: a review (2004) Toxicol Appl Pharmacol, 198, pp. 209-230; \n\nKanluen, S., Gottlieb, C.A., A clinical pathologic study of four adult cases of acute mercury inhalation toxicity (1991) Arch Pathol Lab Med, 115, pp. 56-60; \n\nMiller, S., Pallan, S., Gangji, A.S., Mercury-associated nephrotic syndrome: a case report and systematic review of the literature (2013) Am J Kidney Dis, 62, pp. 135-138; \n\nTang, H.L., Mak, Y.F., Chu, K.H., Minimal change disease caused by exposure to mercury-containing skin lightening cream: a report of 4 cases (2013) Clin Nephrol, 79, pp. 326-329; \n\nChakera, A., Lasserson, D., Beck, L.H., Jr., Membranous nephropathy after use of UK-manufactured skin creams containing mercury (2011) QJM, 104, pp. 893-896; \n\nCahen, R., Trolliet, P., Franccois, B., Fenoprofen-induced membranous glomerulonephritis (1988) Nephrol Dial Transplant, 3, pp. 705-706; \n\nNishimura, M., Uzu, T., Inenaga, T., Membranous nephropathy induced by treatment with ampiroxicam, a nonsteroidal antiinflammatory drug (1999) Nephron, 83, pp. 272-273; \n\nSennesael, J., Van den Houte, K., Verbeelen, D., Reversible membranous glomerulonephritis associated with ketoprofen (1986) Clin Nephrol, 26, pp. 213-215; \n\nMarkowitz, G.S., Falkowitz, D.C., Isom, R., Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib (2003) Clin Nephrol, 59, pp. 137-142; \n\nSugimoto, T., Aoyama, M., Kikuchi, K., Membranous nephropathy associated with the relatively selective cyclooxygenase-2 inhibitor, etodolac, in a patient with early rheumatoid arthritis (2007) Intern Med, 46, pp. 1055-1058; \n\nRadford, M.G., Jr., Holley, K.E., Grande, J.P., Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs (1996) JAMA, 276, pp. 466-469; \n\nPhan, L., Coulomb, F., Boudon, M., [Extramembranous glomerulonephritis induced by lithium] (1991) Nephrologie, 12, pp. 185-187; \n\nIkeda, K., Okamoto, T., Yamamura, T., [Nephrotic syndrome in multiple sclerosis patients who had undergone long-term interferon beta-1b therapy] (2013) Rinsho shinkeigaku (Clinical neurology), 53, pp. 19-23; \n\nden Broeder, A.A., Assmann, K.J., van Riel, P.L., Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis (2003) Neth J Med, 61, pp. 137-141; \n\nStokes, M.B., Foster, K., Markowitz, G.S., Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis (2005) Nephrol Dial Transplant, 20, pp. 1400-1406; \n\nDandona, P., Mier, A., Boag, F., Aprotinin induced lipohypertrophy and glomerulonephritis in an insulin dependent diabetic (1985) Diabetes Res, 2, pp. 213-216; \n\nShin, G.T., Yim, H., Park, J., Membranous nephropathy associated with fluconazole treatment (2007) Am J Kidney Dis, 49, pp. 318-322; \n\nIzzedine, H., Brocheriou, I., Becart, J., Probenecid-induced membranous nephropathy (2007) Nephrol Dial Transplant, 22, pp. 2405-2406; \n\nFerraccioli, G.F., Peri, F., Nervetti, A., Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics (1986) Clin Exp Rheumatol, 4, pp. 9-15; \n\nLindell, A., Denneberg, T., Enestrom, S., Membranous glomerulonephritis induced by 2-mercaptopropionylglycine (2-MPG) (1990) Clin Nephrol, 34, pp. 108-115; \n\nHeymann, W., Nephrotic syndrome after use of trimethadione and paramethadione in petit mal (1967) JAMA, 202, pp. 893-894; \n\nFuruta, T., Seino, J., Saito, T., Insulin deposits in membranous nephropathy associated with diabetes mellitus (1992) Clin Nephrol, 37, pp. 65-69; \n\nBreysse, P., Couser, W.G., Alpers, C.E., Membranous nephropathy and formaldehyde exposure (1994) Ann Intern Med, 120, pp. 396-397; \n\nLee, J.C., Yamauchi, H., Hopper, J., Jr., The association of cancer and the nephrotic syndrome (1966) Ann Intern Med, 64, pp. 41-51; \n\nEagen, J.W., Glomerulopathies of neoplasia (1977) Kidney Int, 11, pp. 297-303; \n\nLewis, M.G., Loughridge, L.W., Phillips, T.M., Immunological studies in nephrotic syndrome associated with extrarenal malignant disease (1971) Lancet, 2, pp. 134-135; \n\nCostanza, M.E., Pinn, V., Schwartz, R.S., Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome (1973) N Engl J Med, 289, pp. 520-522; \n\nBacchetta, J., Juillard, L., Cochat, P., Paraneoplastic glomerular diseases and malignancies (2009) Crit Rev Oncol Hematol, 70, pp. 39-58; \n\nGlassock, R.J., Attending rounds: an older patient with nephrotic syndrome (2012) Clin J Am Soc Nephrol, 7, pp. 665-670; \n\nLavanchy, D., Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures (2004) J Viral Hepat, 11, pp. 97-107; \n\nHirose, H., Udo, K., Kojima, M., Deposition of hepatitis B e antigen in membranous glomerulonephritis: identification by F(ab')2 fragments of monoclonal antibody (1984) Kidney Int, 26, pp. 338-341; \n\nHsu, H.C., Wu, C.Y., Lin, C.Y., Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan (1989) Kidney Int, 36, pp. 1103-1107; \n\nIto, H., Hattori, S., Matusda, I., Hepatitis B e antigen-mediated membranous glomerulonephritis. Correlation of ultrastructural changes with HBeAg in the serum and glomeruli (1981) Lab Invest, 44, pp. 214-220; \n\nLee, H.S., Choi, Y., Yu, S.H., A renal biopsy study of hepatitis B virus-associated nephropathy in Korea (1988) Kidney Int, 34, pp. 537-543; \n\nWiggelinkhuizen, J., Sinclair-Smith, C., Stannard, L.M., Hepatitis B virus associated membranous glomerulonephritis (1983) Arch Dis Child, 58, pp. 488-496; \n\nTang, S., Lai, F.M., Lui, Y.H., Lamivudine in hepatitis B-associated membranous nephropathy (2005) Kidney Int, 68, pp. 1750-1758; \n\nZheng, X.Y., Wei, R.B., Tang, L., Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis (2012) World J Gastroenterol, 18, pp. 821-832; \n\nLiao, M.T., Chang, M.H., Lin, F.G., Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy (2011) Pediatrics, 128, pp. e600-e604; \n\nLai, K.N., Li, P.K., Lui, S.F., Membranous nephropathy related to hepatitis B virus in adults (1991) N Engl J Med, 324, pp. 1457-1463; \n\nJohnson, R.J., Couser, W.G., Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations (1990) Kidney Int, 37, pp. 663-676; \n\nBhimma, R., Coovadia, H.M., Hepatitis B virus-associated nephropathy (2004) Am J Nephrol, 24, pp. 198-211; \n\nGilbert, R.D., Wiggelinkhuizen, J., The clinical course of hepatitis B virus-associated nephropathy (1994) Pediatr Nephrol, 8, pp. 11-14; \n\nLi, P., Wei, R.B., Tang, L., Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy (2012) Clin Nephrol, 78, pp. 456-464; \n\nLatt, N., Alachkar, N., Gurakar, A., Hepatitis C virus and its renal manifestations: a review and update (2012) Gastroenterol Hepatol, 8, pp. 434-445; \n\nMohd Hanafiah, K., Groeger, J., Flaxman, A.D., Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence (2013) Hepatology, 57, pp. 1333-1342; \n\nMorales, J.M., Kamar, N., Rostaing, L., Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy (2012) Contrib Nephrol, 176, pp. 10-23; \n\nUchiyama-Tanaka, Y., Mori, Y., Kishimoto, N., Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review (2004) Clin Nephrol, 61, pp. 144-150; \n\nOkada, K., Takishita, Y., Shimomura, H., Detection of hepatitis C virus core protein in the glomeruli of patients with membranous glomerulonephritis (1996) Clin Nephrol, 45, pp. 71-76; \n\nHunte, W., al-Ghraoui, F., Cohen, R.J., Secondary syphilis and the nephrotic syndrome (1993) J Am Soc Nephrol, 3, pp. 1351-1355; \n\nSanchez-Bayle, M., Ecija, J.L., Estepa, R., Incidence of glomerulonephritis in congenital syphilis (1983) Clin Nephrol, 20, pp. 27-31; \n\nWiggelinkhuizen, J., Kaschula, R.O., Uys, C.J., Congenital syphilis and glomerulonephritis with evidence for immune pathogenesis (1973) Arch Dis Child, 48, pp. 375-381; \n\nYuceoglu, A.M., Sagel, I., Tresser, G., The glomerulopathy of congenital syphilis. A curable immune-deposit disease (1974) JAMA, 229, pp. 1085-1089; \n\nThomas, E.W., Schur, M., Clinical nephropathies in early syphilis (1946) Arch Intern Med, 78, p. 1; \n\nHerrmann, G., Marr, W.L., Clinical syphilitic nephropathies. A study of new cases and survey of reproted cases (1935) Am J Syph Neurol, 19, p. 1; \n\nKaschula, R.O., Uys, C.J., Kuijten, R.H., Nephrotic syndrome of congenital syphilis. Biopsy studies in four cases (1974) Arch Pathol, 97, pp. 289-296; \n\nTourville, D.R., Byrd, L.H., Kim, D.U., Treponemal antigen in immunopathogenesis of syphilitic glomerulonephritis (1976) Am J Pathol, 82, pp. 479-492; \n\nO'Regan, S., Fong, J.S., de Chadarevian, J.P., Treponemal antigens in congenital and acquired syphilitic nephritis: demonstration by immunofluorescence studies (1976) Ann Intern Med, 85, pp. 325-327; \n\nWalker, P.D., Deeves, E.C., Sahba, G., Rapidly progressive glomerulonephritis in a patient with syphilis. Identification of antitreponemal antibody and treponemal antigen in renal tissue (1984) Am J Med, 76, pp. 1106-1112; \n\nChavaz, A., Mignon, F., Morel-Maroger, L., [Extramembranous glomerulitis. Apropos of 92 cases] (1977) Schweiz Med Wochenschr, 107, pp. 899-907; \n\nAltay, M., Unverdi, S., Altay, F.A., Renal injury due to hepatic hydatid disease (2010) Nephrol Dial Transplant, 25, pp. 2611-2615; \n\nEdelweiss, M.I., Daudt, H.M., Goldstein, H.F., [Hepatic hydatidosis with glomerular involvement: report of a case] (1992) Rev Assoc Med Bras, 38, pp. 31-32; \n\nSanchez Ibarrola, A., Sobrini, B., Guisantes, J., Membranous glomerulonephritis secondary to hydatid disease (1981) Am J Med, 70, pp. 311-315; \n\nSobh, M.A., Moustafa, F.E., Sally, S.M., Characterisation of kidney lesions in early schistosomal-specific nephropathy (1988) Nephrol Dial Transplant, 3, pp. 392-398; \n\nRam, R., Swarnalatha, G., Desai, M., Membranous nephropathy and granulomatous interstitial nephritis due to tuberculosis (2011) Clin Nephrol, 76, pp. 487-491; \n\nRodriguez-Garcia, J.L., Fraile, G., Mampaso, F., Pulmonary tuberculosis associated with membranous nephropathy (1990) Nephron, 55, pp. 218-219; \n\nDempsey, O.J., Paterson, E.W., Kerr, K.M., Sarcoidosis (2009) BMJ, 339, p. b3206; \n\nMuther, R.S., McCarron, D.A., Bennett, W.M., Renal manifestations of sarcoidosis (1981) Arch Intern Med, 141, pp. 643-645; \n\nBijol, V., Mendez, G.P., Nose, V., Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution (2006) Int J Surg Pathol, 14, pp. 57-63; \n\nJavaud, N., Belenfant, X., Stirnemann, J., Renal granulomatoses: a retrospective study of 40 cases and review of the literature (2007) Medicine, 86, pp. 170-180; \n\nStehle, T., Joly, D., Vanhille, P., Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study (2013) Orphanet J Rare Dis, 8, p. 65; \n\nTaylor, R.G., Fisher, C., Hoffbrand, B.I., Sarcoidosis and membranous glomerulonephritis: a significant association (1982) Br Med J (Clin Res Ed), 284, pp. 1297-1298; \n\nTroxell, M.L., Pilapil, M., Miklos, D.B., Renal pathology in hematopoietic cell transplantation recipients (2008) Mod Pathol, 21, pp. 396-406; \n\nHiesse, C., Goldschmidt, E., Santelli, G., Membranous nephropathy in a bone marrow transplant recipient (1988) Am J Kidney Dis, 11, pp. 188-191; \n\nLin, J., Markowitz, G.S., Nicolaides, M., Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature (2001) Am J Nephrol, 21, pp. 351-356; \n\nQuaranta, S., Shulman, H., Ahmed, A., Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation (1999) Clin Immunol, 91, pp. 106-116; \n\nKline, J., van Besien, K., Nathanson, J., Severe intestinal graft-versus-host disease following autologous stem cell transplantation (2006) Bone Marrow Transplant, 38, pp. 391-392; \n\nZenz, T., Ritgen, M., Dreger, P., Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia (2006) Blood, 108, pp. 2127-2130; \n\nBruijn, J.A., Hogendoorn, P.C., Corver, W.E., Pathogenesis of experimental lupus nephritis: a role for anti-basement membrane and anti-tubular brush border antibodies in murine chronic graft-versus-host disease (1990) Clin Exp Immunol, 79, pp. 115-122; \n\nTruong, L., Gelfand, J., D'Agati, V., De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature (1989) Am J Kidney Dis, 14, pp. 131-144; \n\nLarsen, C.P., Walker, P.D., Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy (2013) Transplantation, 95, pp. 1259-1262; \n\nBecker, B.A., Fenves, A.Z., Breslau, N.A., Membranous glomerulonephritis associated with Graves' disease (1999) Am J Kidney Dis, 33, pp. 369-373; \n\nGrcevska, L., Polenakovic, M., Petrusevska, G., Membranous nephropathy associated with thyroid disorders (2000) Nephron, 86, pp. 534-535; \n\nHorvath, F., Jr., Teague, P., Gaffney, E.F., Thyroid antigen associated immune complex glomerulonephritis in Graves' disease (1979) Am J Med, 67, pp. 901-904; \n\nJordan, S.C., Buckingham, B., Sakai, R., Studies of immune-complex glomerulonephritis mediated by human thyroglobulin (1981) N Engl J Med, 304, pp. 1212-1215; \n\nKocak, G., Huddam, B., Azak, A., Coexistent findings of renal glomerular disease with Hashimoto's thyroiditis (2012) Clin Endocrinol (Oxf), 76, pp. 759-762; \n\nWeetman, A.P., Tomlinson, K., Amos, N., Proteinuria in autoimmune thyroid disease (1985) Acta Endocrinol, 109, pp. 341-347; \n\nDavies, T.F., Ando, T., Lin, R.Y., Thyrotropin receptor-associated diseases: from adenomata to Graves disease (2005) J Clin Invest, 115, pp. 1972-1983; \n\nChiovato, L., Bassi, P., Santini, F., Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis (1993) J Clin Endocrinol Metab, 77, pp. 1700-1705; \n\nChurchill, D.N., Farid, N., Proteinuria in Hashimoto thyroiditis (1981) N Engl J Med, 305, p. 1286; \n\nHorikoshi, T., Tamura, J., Kaneko, Y., Membranous nephropathy associated with chronic thyroiditis (1993) Nephron, 63, p. 246; \n\nTaniguchi, Y., Yorioka, N., Katsutani, M., Hemophagocytic syndrome in a patient with Hashimoto's thyroiditis and membranous nephritis (1999) Nephron, 81, pp. 246-247; \n\nStone, J.H., Zen, Y., Deshpande, V., IgG4-related disease (2012) N Engl J Med, 366, pp. 539-551; \n\nCornell, L.D., IgG4-related kidney disease (2012) Semin Diagn Pathol, 29, pp. 245-250; \n\nAlexander, M.P., Larsen, C.P., Gibson, I.W., Membranous glomerulonephritis is a manifestation of IgG4-related disease (2013) Kidney Int, 83, pp. 455-462; \n\nKhosroshahi, A., Ayalon, R., Beck, L.H., Jr., IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor (2012) Int J Rheumatol, 2012, p. 139409; \n\nStone, J.H., Khosroshahi, A., Deshpande, V., Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations (2012) Arthritis Rheum, 64, pp. 3061-3067; \n\nChen, K.H., Chang, C.T., Hung, C.C., Glomerulonephritis associated with chronic inflammatory demyelinating polyneuropathy (2006) Ren Fail, 28, pp. 255-259; \n\nOlbricht, C.J., Stark, E., Helmchen, U., Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: a case report and review of the literature (1993) Nephron, 64, pp. 139-141; \n\nPanjwani, M., Truong, L.D., Eknoyan, G., Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies (1996) Am J Kidney Dis, 27, pp. 279-283; \n\nPonticelli, C., Glassock, R.J., Posttransplant recurrence of primary glomerulonephritis (2010) Clin J Am Soc Nephrol, 5, pp. 2363-2372; \n\nJosephson, M.A., Spargo, B., Hollandsworth, D., The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review (1994) Am J Kidney Dis, 24, pp. 873-878; \n\nDabade, T.S., Grande, J.P., Norby, S.M., Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study (2008) Am J Transplant, 8, pp. 1318-1322; \n\nInnes, A., Woodrow, G., Boyd, S.M., Recurrent membranous nephropathy in successive renal transplants (1994) Nephrol Dial Transplant, 9, pp. 323-325; \n\nRodriguez, E.F., Cosio, F.G., Nasr, S.H., The pathology and clinical features of early recurrent membranous glomerulonephritis (2012) Am J Transplant, 12, pp. 1029-1038; \n\nIvanyi, B., A primer on recurrent and de novo glomerulonephritis in renal allografts (2008) Nat Clin Pract Nephrol, 4, pp. 446-457; \n\nAline-Fardin, A., Rifle, G., Martin, L., Recurent and de novo membranous glomerulopathy after kidney transplantation (2009) Transplant Proc, 41, pp. 669-671; \n\nEl Kossi, M., Harmer, A., Goodwin, J., De novo membranous nephropathy associated with donor-specific alloantibody (2008) Clin Transplant, 22, pp. 124-127; \n\nHonda, K., Horita, S., Toki, D., De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney (2011) Clin Transplant, 25, pp. 191-200; \n\nLim, B.J., Kim, M.S., Kim, Y.S., C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury (2012) Transplant Proc, 44, pp. 619-620; \n\nDebiec, H., Hanoy, M., Francois, A., Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor (2012) J Am Soc Nephrol, 23, pp. 1949-1954; \n\nCameron, J.S., Coagulation and thromboembolic complications in the nephrotic syndrome (1984) Adv Nephrol Necker Hosp, 13, pp. 75-114; \n\nGlassock, R.J., Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum (2007) J Am Soc Nephrol, 18, pp. 2221-2225; \n\nSinghal, R., Brimble, K.S., Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management (2006) Thromb Res, 118, pp. 397-407; \n\nLlach, F., Papper, S., Massry, S.G., The clinical spectrum of renal vein thrombosis: acute and chronic (1980) Am J Med, 69, pp. 819-827; \n\nTrew, P.A., Biava, C.G., Jacobs, R.P., Renal vein thrombosis in membranous glomerulonephropathy: incidence and association (1978) Medicine, 57, pp. 69-82; \n\nLaville, M., Aguilera, D., Maillet, P.J., The prognosis of renal vein thrombosis: a re-evaluation of 27 cases (1988) Nephrol Dial Transplant, 3, pp. 247-256; \n\nWagoner, R.D., Stanson, A.W., Holley, K.E., Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance (1983) Kidney Int, 23, pp. 368-374; \n\nBarbour, S.J., Greenwald, A., Djurdjev, O., Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis (2012) Kidney Int, 81, pp. 190-195; \n\nMarkowitz, G.S., Brignol, F., Burns, E.R., Renal vein thrombosis treated with thrombolytic therapy: case report and brief review (1995) Am J Kidney Dis, 25, pp. 801-806", "hasCitationDuplums" : false, "userChangeableUntil" : "2017-01-02T11:20:56.000+0000", "publishDate" : "2016-10-04T10:20:56.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 5, "ownerInstituteCount" : 9, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 30238560, "link" : "/api/publication/30238560", "label" : "J. Charles Jennette. Heptinstall's Pathology of the Kidney. (2014) ISBN:9781469887555; 9781451144116", "core" : false, "citation" : false, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000201, "link" : "/api/subtype/10000201", "label" : "Szakkönyv (Könyv)", "name" : "Szakkönyv", "nameEng" : "Monograph", "docType" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "listPosition" : 337, "published" : true, "oldId" : 10000201, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "Heptinstall's Pathology of the Kidney", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 11292882, "link" : "/api/publicationidentifier/11292882", "label" : "ISBN: 9781469887555", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9781469887555", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9781469887555", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 11579586, "link" : "/api/publicationidentifier/11579586", "label" : "ISBN: 9781451144116", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9781451144116", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9781451144116", "published" : false, "snippet" : true } ], "publishedAt" : [ { "otype" : "City", "mtid" : 10233, "link" : "/api/city/10233", "label" : "Philadelphia (PA), Amerikai Egyesült Államok", "partOf" : { "otype" : "Country", "mtid" : 10017, "link" : "/api/country/10017", "label" : "Amerikai Egyesült Államok", "published" : true, "oldId" : 13, "snippet" : true }, "published" : true, "oldId" : 354, "snippet" : true } ], "pageLength" : 1592, "publishedYear" : 2014, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "published" : true, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/26107061", "label" : "Markowitz GS et al. Membranous glomerulonephritis. (2014) Megjelent: Heptinstall's Pathology of the Kidney", "template" : "